Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hasbro, Inc. (HAS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Hasbro, Inc.Trade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Hasbro, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Hasbro, Inc. trades at $97.48 (market cap $13.69B), while State Street SPDR S&P Biotech ETF trades at $158.17. The key difference: Hasbro, Inc. pays a 2.89% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Hasbro, Inc. nearer its low. Which is the better fit depends on your goals.

HASXBI
Market Cap
$13.69B
Sector
Consumer CyclicalBroad Market / Factor
52-Week High
$105.88$164.28
52-Week Low
$70.95$86.92
Enterprise Value
$15.88B
Dividend Yield
2.89%

Returns comparison

Trailing returns across standard periods

About Hasbro, Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.

Read more on HAS

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI